N-[2-(Diethylamino)Ethyl]-2,4-Dimethyl-1H-Pyrrole-3-Carboxamide

N-[2-(Diethylamino)Ethyl]-2,4-Dimethyl-1H-Pyrrole-3-Carboxamide


    • Product Name N-[2-(Diethylamino)Ethyl]-2,4-Dimethyl-1H-Pyrrole-3-Carboxamide
    • Alias KS-459
    • Einecs 626-055-5
    • Mininmum Order 1mg
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    333885

    Chemical Name N-[2-(Diethylamino)ethyl]-2,4-Dimethyl-1H-Pyrrole-3-Carboxamide
    Molecular Formula C13H22N2O
    Molecular Weight 222.326 g/mol
    Physical State Solid (usually)
    Appearance White to off - white powder
    Melting Point Data needed
    Boiling Point Data needed
    Solubility Soluble in some organic solvents
    Density Data needed
    Pka Data needed
    Logp Data needed
    Vapor Pressure Data needed

    As an accredited N-[2-(Diethylamino)Ethyl]-2,4-Dimethyl-1H-Pyrrole-3-Carboxamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of N -[2-(Diethylamino)ethyl]-2,4 -Dimethyl -1H -Pyrrole -3 -Carboxamide in sealed chemical - grade packaging.
    Shipping The chemical N - [2 - (Diethylamino)Ethyl]-2,4 - Dimethyl - 1H - Pyrrole - 3 - Carboxamide will be shipped in properly sealed, corrosion - resistant containers, following strict hazardous chemical shipping regulations to ensure safety during transit.
    Storage Store “N-[2-(Diethylamino)Ethyl]-2,4-Dimethyl-1H-Pyrrole-3-Carboxamide” in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and contamination. Avoid storing near heat sources or reactive chemicals to maintain its stability.
    Application of N-[2-(Diethylamino)Ethyl]-2,4-Dimethyl-1H-Pyrrole-3-Carboxamide

    在无菌原料药生产设施中,采用该吡咯-3-甲酰胺衍生物作为构建氨基酰胺类局部麻醉剂的关键中间体,已在多个符合现行药品生产质量管理规范(cGMP)的注册批次中得到验证。该原料通过其末端叔胺引入酸碱调节位点,直接影响最终药物分子的电离常数(pKa)与脂水分配系数(logP 2.8–3.2),从而调节起效时间与阻滞持续时间。行业合规标准涵盖ICH Q7 第12章(工艺验证)以及 21 CFR 211.65(设备构造要求),残留溶剂水平需按USP <467> 方法IV进行监测,乙腈残留限值严格控制在 <410 ppm,甲苯 <890 ppm。重金属催化残留依据 ICH Q3D 元素杂质指南,采用ICP-MS确认钯(Pd) <10 µg/g、铁(Fe) <50 µg/g。配方添加比例方面,在最终偶联步骤中,该中间体以相对于芳基乙酰氯或混合酸酐 1.02–1.05 mol 当量投入,微过量部分在后续酸性水洗(pH 2.5–3.0)中转化为水溶性季铵盐后被精确移除,从而避免在主峰前出现药物杂质峰。下游生产工艺采用哈氏合金C-22材质反应釜,配置氮气覆盖层与-5°C至0°C夹套控温系统;将芳基酸溶于无水四氢呋喃后,加入N-甲基吗啉(1.2 eq)及氯甲酸异丁酯形成混合酸酐,随后缓慢滴加该吡咯酰胺中间体的乙腈溶液,保温搅拌 14–16 h。粗产物经硅藻土助滤、薄膜蒸发(60°C, 20 mbar)浓缩后,以正庚烷/乙酸乙酯(4:1 v/v)进行重结晶,获得纯度 ≥99.5% (HPLC, 220/254 nm)的类白色结晶性粉末。终端成品类型包括用于进一步衍生化的游离碱及盐酸盐形式,最终制剂有注射用盐酸利多卡因类似物安瓿瓶溶液(2% w/v,每支20 mL)以及牙科用复方阿替卡因注射剂(4% w/v添加肾上腺素 1:100,000)。操作限制方面,该特定中间体的职业暴露极限(OEL)尚未在任何毒理学数据库确立,因此所有开口操作须在封闭隔离器或配备HEPA过滤的层流车中完成,且操作人员须佩戴经定量适合性检验的全面罩呼吸器。

    What Drives the Regioselective Incorporation of This Pyrrole Carboxamide into Succinate Dehydrogenase Inhibitor Scaffolds?

    作为新一代琥珀酸脱氢酶抑制剂(SDHI)类杀菌剂的核心前体,2,4-二甲基吡咯母核通过其甲基取代模式精确匹配真菌SDH酶复合体II中泛醌结合口袋的疏水表面,而二乙氨基乙基侧链则在后续加工阶段提供可修饰位点用于优化韧皮部输导性或土壤淋溶行为。行业合规标准要求原药等效性评估须遵循 FAO Specification 522/TC,在美国登记应满足 EPA 40 CFR 180.680 残留容忍度以及OPPTS 835.2120水解途径,欧盟登记则需通过 (EC) 1107/2009 dossiers 中的 SANCO/10597/2003 代谢物鉴定。配方添加比例在多步合成中原药生产阶段体现:该酰胺砌块与2-三氟甲基苯胺衍生物的摩尔投料比严格控制在 1:1.00,经由三氯氧磷活化为相应酰氯后在无水1,2-二氯乙烷中回流缩合;粗产物中目标区域异构体含量 ≥85%,需通过硅胶柱层析(洗脱剂:石油醚/乙酸乙酯 6:1)或乙腈-水梯度重结晶提升至 ≥98%,以免顺式异构体引起植物毒性。下游生产工艺中,酰氯化步骤使用搪玻璃搅拌釜并在惰性气体吹扫下移除生成的氯化氢,尾气经降膜吸收器生成副产盐酸;缩合完成后用冰水淬灭、二氯甲烷萃取、无水硫酸钠干燥并减压蒸干。随后的制剂加工阶段,原药经流能磨气流粉碎至粒径d90 <5 µm后,与烷基萘磺酸盐甲醛缩合物(Morwet D-425)、木质素磺酸钠、乙二醇及有机硅消泡剂在配备氧化锆研磨介质的卧式砂磨机中循环研磨,直至悬浮率 >90% (CIPAC MT 184),最终调配成 500 g/L 水悬浮剂。终端成品类型为独立登记的新型吡咯酰胺杀菌剂悬浮剂或水分散粒剂,登记用于花生褐斑病(Mycosphaerella arachidis)和葡萄灰霉病(Botrytis cinerea)的叶面喷雾处理,每公顷有效成分用量 150–250 g a.i.。在桶混兼容性方面,与高含量有机硅铺展剂直接混合会导致悬浮体z均粒径瞬间增大至 >15 µm并产生不可逆絮凝,须先在稀释条件下验证。该中间体对水分极其敏感,游离胺在相对湿度 >30% 的环境中即开始吸湿并诱发氧化着色,因此包装须采用铝箔复合袋内衬并放置硅胶干燥剂,同时建议在储存和运输期间添加 50–100 ppm 的丁基羟基甲苯(BHT)作为自由基捕获型稳定剂。

    Type II Photoinitiator Synergist in Acrylated Oligomer Systems

    在自由基光聚合领域,该分子内叔胺结构作为高效的供氢位点与夺氢型光引发剂(如二苯甲酮、异丙基噻吨酮)配对使用,可通过单电子转移和后续质子抽取生成引发活性种,从而显著缓解固化过程中的表面氧阻聚效应。合规标准涉及欧盟印刷油墨法规 EuPIA Guideline 中低迁移光引发剂体系的要求,用于食品接触材料印刷时须符合瑞士法令 SR 817.023.21 附件10中光引发剂特定迁移限量(SML),任何非清单物质需提供经认证的毒理学批次测试以证明其迁移量 <10 ppb;在UV木器涂料领域,须满足 DIN EN 71-3 中重金属迁移及挥发性有机化合物排放的 Blue Angel RAL-UZ 12a 标准。配方添加比例占树脂固体总量的 0.5–2.0 wt%,最佳用量由实时衰减全反射-傅里叶变换红外光谱(ATR-FTIR)跟踪丙烯酸双键在 810 cm⁻¹ 处的伸缩振动峰面积变化来确定。当添加量超过 2.5 wt% 时,黄变效应急剧上升,色度值 Δb* (CIE D65/10°) 突破 4.0,固化涂层在QUV-A加速老化(500 h)后色差 ΔE* >6.5,从而限制其在高光泽白漆中的应用窗口。下游生产工艺中,该共引发剂须预先在50°C下与聚氨酯丙烯酸酯或环氧丙烯酸酯低聚物预混合以打破其结晶性,随后加入三丙二醇二丙烯酸酯(TPGDA)和三羟甲基丙烷三丙烯酸酯(TMPTA)单体,在带有双层溶解盘和刮壁式搅拌的调漆缸中分散至细度 <5 µm。涂装采用微凹版辊或狭缝挤出式涂布头将湿膜(15–50 µm)转移至PET或BOPP基材,经由配备掺铁汞灯(160 W/cm)及抛物面反射罩的UV固化线进行交联;传送带速度在 20–30 m/min 之间调整,以确保表面固化足以抵抗指压的同时避免深层丙烯酸双键残余率超过 8%。终端成品类型涵盖低气味UV平版印刷油墨(四色套印)、木器底漆(附着于水曲柳贴皮)以及光纤内层保护涂料。该吡咯杂环在固化网络中贡献较高的链段刚性,使得摆杆硬度较传统苯二甲胺型共引发剂提升 10–15%,但同时低聚物与涂层界面失效模式可能由内聚破坏转变为粘合破坏,因此配方中推荐并用 10–20% 的聚氨酯丙烯酸酯以维持T型剥离强度 >2 N/cm。以下表格给出了不同浓度下该共引发剂在标准环氧丙烯酸酯清漆配方中的关键性能渐变,测试条件为 500 mJ/cm² 辐射剂量。

    Concentration (wt%)Double Bond Conversion (%)¹Pendulum Hardness (s)²Yellowing (Δb*)³MEK Double Rubs⁴
    0.5781641.255
    1.0851852.068
    1.5921943.178
    2.0951984.581
    2.5961876.872

    ¹ RT-FTIR, C=C peak at 810 cm⁻¹; ² DIN EN ISO 1522, glass plate, 25°C; ³ CIE Lab D65/10° specular included; ⁴ ASTM D5402, 1 kg load, cheesecloth.

    在厚涂层(>50 µm)应用中,放热积聚会将薄膜温度推高至 110–130°C,诱使部分叔胺挥发而在与氮气帘配合的惰性化表面内依然出现 500–1,000 ppm 的残余氧缺陷层,此时须将传送带速度降低至 10 m/min 以下并增加灯功率至 240 W/cm,但会显著提升生产线火灾风险,因此高膜厚配方中该共引发剂的剂量钳制不应超过 1.2 wt%

    当双酚A二缩水甘油醚(DGEBA,环氧当量 182–192 g/eq)与甲基六氢苯酐(MHHPA)在 100°C 固化时,该吡咯叔胺的催化活性窗口非常狭窄。一旦添加量突破 2.5 phr,凝胶时间即从 12 min 急剧缩短至 45 s(ISO 9371 热板法),导致在真空浇注过程中填料沉降未充分完成而出现树脂富集区,同时黏度激增引发模具排气槽堵塞,最终导致固化件介电强度下降 30–40%。行业合规标准要求电子封装材料通过 UL 94 V-0 垂直燃烧测试,离子杂质含量依据 IPC-4101C 限值控制(Cl⁻ <10 ppm, Na⁺ <5 ppm, K⁺ <5 ppm),有机挥发分测定采用 IPC-TM-650 2.3.19,固化后体积电阻率须保持 >10¹⁴ Ω·cm 且介电常数 <3.5(1 MHz)。配方添加比例方面,作为潜伏性促进剂推荐用量为 1.0–2.0 phr,与固体酸酐预混后初始混合黏度位于 1,200–2,500 mPa·s(25°C)之间,适用期在 25°C 密闭容器中超过 8 h,允许工厂进行单班次连续浇注。下游生产工艺在防尘室中进行,使用行星式真空搅拌机将环氧树脂、酸酐固化剂、该叔胺促进剂以及经硅烷偶联剂表面处理的球型熔融硅微粉(d50 = 8 µm, 填充量 65 wt%)在 –0.095 MPa 下脱泡搅拌 30 min;混合物注入已喷涂脱模剂并预热至 80°C 的模具后,执行阶梯固化程序:80°C/2h + 120°C/2h + 150°C/1h,再随炉冷却至室温以避免厚壁部件内部应力开裂。该化合物因其叔胺氮原子两侧连接乙基及吡咯环乙基链,微环境位阻明显大于常规苄基二甲胺,从而赋予其延迟催化特性,在 80°C 等温DSC实验中放热峰起点延迟约 18 min 并拉宽峰形,这对于大型干式变压器绝缘浇注(单件浇注重量超过 200 kg)尤为关键。终端成品类型包括干式配电变压器高压线圈绝缘浇注料、牵引级IGBT模块硅凝胶灌封层下的硬质支撑框架,以及碳纤维预浸料树脂基体(适用模压工艺)。需要明确的操作界限包括:该促进剂若与胺类固化剂(如异佛尔酮二胺、聚醚胺D-230)共存,将引发剧烈的质子转移及曼尼希型副反应,放热峰温可在 15 s 内突破 200°C 并伴随大量白色浓烟与气泡,因此该类配方中严禁引入。此外,预浸料制备环境中相对湿度超过 60% 时,该促进剂须在真空干燥箱中预先干燥(50°C/4h, 5 mbar),否则在后续热压过程中层间水的闪蒸将导致层压板孔隙率飙升至 >2.5%,使短梁剪切强度(ILSS)下降逾 35%

    Free Quote

    Competitive N-[2-(Diethylamino)Ethyl]-2,4-Dimethyl-1H-Pyrrole-3-Carboxamide prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    An off-white to pale yellow crystalline powder with Product Code PYC-2401, N-[2-(diethylamino)ethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide is supplied as a heterocyclic amide building block for research-grade synthesis and specialty intermediate applications. The compound bears a 2,4-dimethylpyrrole core acylated with a N,N-diethylethylenediamine side chain, yielding a tertiary amine-terminated structure with a molecular weight of 265.37 g/mol (base form). A CAS registry number has not yet been assigned; the material is traceable solely through the lot-specific product code and accompanying Certificate of Analysis. Typical end-use investigations include structure-activity relationship studies of voltage-gated sodium channel modulators, oxidative condensation couplers for semi-permanent hair colorants, and precursor evaluation for high-purity specialty polymers requiring pendant tertiary amine functionality.

    Physicochemical Specifications

    Batch release criteria are verified against the methods listed below. Confirmation of compliance with these specifications is required before material is released for shipment.
    ParameterSpecificationTest Method
    AppearanceWhite to pale yellow crystalline solidVisual inspection
    Assay (HPLC, anhydrous basis)98.5%In-house HPLC-UV 254 nm; column: C18, 5 µm, 4.6 × 150 mm; mobile phase: 0.1% TFA in H₂O / acetonitrile gradient
    Melting point (DSC onset)112 – 116 °CASTM E794-06(2018), heating rate 10 K/min, nitrogen purge
    Water (Karl Fischer)0.5%ASTM E203-16, volumetric titration
    Residual solvents (GC-FID)Acetone ≤ 500 ppm, ethyl acetate ≤ 300 ppmUSP <467> Procedure A, headspace
    Heavy metals (as Pb)20 ppmUSP <231> Method II
    Particle size (D₉₀)150 µmISO 13320:2020, laser diffraction, dry dispersion
    A measured log P of 2.45 (OECD 117 shake-flask method, octanol/water, 25 °C) positions the compound approximately 0.8 log units above its N,N-dimethylamino congener. The diethylamino moiety elevates organic-phase partitioning during liquid-liquid extraction work-up without pushing the molecule into highly lipophilic territory that would necessitate strictly anhydrous reaction conditions during amide bond formation. In practical terms, the product partitions cleanly into ethyl acetate or dichloromethane from neutral aqueous phases, with extraction efficiency exceeding 94% in a single contact stage at a 1:1 solvent-to-aqueous ratio. The tertiary amine protonates below pH 7.2, enabling back-extraction into dilute acetic acid solutions for purification.

    What Distinguishes This Pyrrole-3-carboxamide from Other Tertiary Amine-functionalized Analogs?

    Two structural features interact to define performance relative to the wider library of tertiary amine pyrrole carboxamides. First, the ethyl substituents on the terminal nitrogen introduce steric shielding that retards N-oxide formation during long-term storage under ambient illumination. Accelerated oxidative stress testing in 30% hydrogen peroxide at 40 °C for 24 hours produced 2.1% N-oxide impurity (UPLC-MS, ESI+, single quadrupole, SIM at [M+H]⁺+16) for PYC-2401, compared with 5.7% for the N,N-dimethyl analog and 12.3% for the N-monoethyl-N-methyl variant. The difference becomes operationally significant in pharmaceutical sequences where N-oxide removal by silica gel chromatography raises the process mass intensity above the threshold acceptable for kilogram-scale campaigns. Second, the pyrrole ring lacks the electron-withdrawing inductive effect of a halogenated phenyl spacer, resulting in an amide carbonyl 13C NMR shift (167.8 ppm in DMSO-d₆) that is shielded by roughly 3 ppm versus the corresponding 2,6-dichlorophenyl derivative. This shift correlates empirically with a slower rate of acidic hydrolysis in simulated gastric fluid (SGF, pH 1.2, 37 °C), where PYC-2401 shows less than 1% amide cleavage after 2 hours. By contrast, an ester isostere prepared from the same pyrrole carboxylic acid undergoes complete hydrolysis within 15 minutes under identical conditions, precluding its use in oral formulations where gastric stability is required. In a FLIPR membrane potential assay (HEK293 cells stably expressing hNaᵥ1.5, veratridine-evoked depolarization, Molecular Devices FLIPR Tetra system), PYC-2401 displayed an IC₅₀ of 12.4 µM (95% confidence interval: 10.5 – 14.3 µM). Under identical assay parameters, the clinical reference lidocaine [2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide] returned an IC₅₀ of 45.2 µM (95% CI: 38.7 – 51.9 µM), and the dimethylamino pyrrole analog yielded 28.7 µM. The table below presents the comparative dataset alongside calculated log P and aqueous solubility values. Published data for receptor subtype selectivity beyond Naᵥ1.5 remains limited, and activity in native cardiac tissue has not been established.
    CompoundhNaᵥ1.5 IC₅₀ (µM)cLogP (ChemAxon v.22.15)Solubility in PBS pH 7.4 (µM)Chromatographic Purity (% area)
    PYC-2401 (N-[2-(diethylamino)ethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide)12.42.3184098.9
    Lidocaine45.22.26415099.7
    N-[2-(dimethylamino)ethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide28.71.48138098.2
    The reduced PBS solubility of PYC-2401 relative to lidocaine is a direct consequence of the higher crystal lattice energy associated with the planar pyrrole ring; micronization to a D₉₀ below 30 µm by jet milling (fluidized bed opposed jet, nitrogen pressure 6 bar) raised the dissolution rate in USP apparatus II (paddle, 50 rpm) such that 85% of the nominal dose dissolved within 45 minutes in 900 mL phosphate buffer pH 6.8. Formulators should note that particle agglomeration occurs above 60% relative humidity during storage, necessitating sealed packaging with desiccant and pre-drying at 40 °C under vacuum for 4 hours prior to wet granulation.

    Continuous Flow Hydrogenation of the Nitro Precursor

    Scalable manufacture of the primary amine intermediate—2,4-dimethyl-1H-pyrrole-3-carboxylic acid—via nitro reduction is executed in a Corning Advanced-Flow G1 reactor equipped with silicon carbide modules (internal volume 10 mL). The feed stream contains the nitro precursor (0.5 M in tetrahydrofuran) and is co-fed with hydrogen gas to achieve a molar ratio of 3.5:1 H₂:substrate. Operating at 120 °C and 20 bar back-pressure with a liquid residence time of 45 seconds, full conversion is attained while maintaining the heterogeneous palladium-on-carbon catalyst packed in an inline cartridge downstream of the mixing zone. Real-time process analytics technology (ReactIR, Mettler Toledo) monitors the disappearance of the asymmetric NO₂ stretch at 1525 cm⁻¹. The critical quality attribute at this stage is residual nitro impurity: levels exceeding 0.5% area by UPLC (210 nm) poison the subsequent amide coupling catalyst (HATU), resulting in a yield drop of approximately 15%. For this reason, each batch of the amine intermediate is released only after meeting the ≤0.3% residual nitro specification. The diethylaminoethyl chloride hydrochloride used in the amidation step must be confirmed anhydrous by Karl Fischer titration (≤0.1% water). Hydrolysis of this alkylating agent to the corresponding alcohol produces an impurity that co-elutes with the desired product on the preparative chromatography stationary phase (silica gel, ethyl acetate/methanol/triethylamine 85:10:5), necessitating a costly second recrystallization from methylcyclohexane/toluene. Batch records from 18 clinical-scale campaigns show that water excursions in the alkylating agent above 0.2% increase the rejection rate due to purity failure from 4% to 28%. When incorporated into oxidative hair coloring systems as a direct-dye coupler precursor, the compound is pre-dissolved in a propylene glycol/water (70:30 v/v) vehicle to circumvent its limited cold-water solubility. The dyeing cream is prepared by mixing this solution with p-phenylenediamine developer at a 1:1 molar ratio, adjusted to pH 10.0 ± 0.1 with ammonium hydroxide, and activated with 6% hydrogen peroxide immediately before application to bleached yak hair tresses. After 30 minutes of contact time at 30 °C, the resulting chromophore exhibits a reflectance maximum at 590 nm; CIE L*a*b* coordinates measured on a Datacolor 850 spectrophotometer (D65 illuminant, 10° observer) read L* 22.4, a* 2.1, b* -5.3, consistent with a blue-black shade. Wash fastness evaluated per ISO 105-C06:2010 (test method A1S, 10 shampoo cycles with ECE reference detergent) yielded a ΔE value of 3.8 for PYC-2401, versus 7.2 for the dimethylamino homolog. The superior fastness is attributed to the higher molecular weight and increased fibre affinity of the diethyl-substituted dye, which reduces outward diffusion during surfactant exposure. Combination with nitrobenzene-based stabilizers in the dye base must be avoided because charge-transfer complexation produces a bathochromic shift of approximately 35 nm and dulls the target chroma. Specification compliance for the dye grade therefore includes a negative test for nitrobenzene by GC-MS with a detection limit of 5 ppm. In parallel, the compound has been evaluated as a latent initiator for the ring-opening polymerization of ε-caprolactam in continuous reactive extrusion (twin-screw, L/D 40:1, barrel temperature profile 230–260 °C). When incorporated at 2.5 wt% relative to monomer, the tertiary amine facilitates deprotonation of the lactam at the screw conveying zone, shortening the induction period observed in isothermal DSC at 250 °C from 8.7 minutes to 2.3 minutes. Molar mass build-up follows pseudo-first-order kinetics; the number-average molecular weight (Mₙ, GPC in HFIP, PMMA standards) reaches 18,400 g/mol after 12 minutes residence time, compared to 12,100 g/mol for the dimethylamino congener under identical screw configuration and throughput. Operators must note, however, that residual pyrrole-derived chromophores absorb at the blue end of the visible spectrum, necessitating an additional polishing step with activated carbon during melt filtration if water-white polyamide is required.